This study demonstrates that TGF-β1 levels in the small airway tissue of smokers with and without COPD is significantly suppressed compared to normal controls (non-smokers and is associated with the activation of the SMAD pathway via pSMAD2/3. This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.